A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer
(Q36509678)
scientific article published on July 2003
scientific article published on July 2003
Language:
Current Data About
A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer